Prudential Financial Inc. increased its position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 1.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 282,148 shares of the medical equipment provider’s stock after acquiring an additional 3,470 shares during the period. Prudential Financial Inc. owned approximately 0.14% of Zimmer Biomet Holdings worth $33,037,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the stock. Enterprise Financial Services Corp increased its holdings in Zimmer Biomet Holdings by 0.3% during the 2nd quarter. Enterprise Financial Services Corp now owns 2,646 shares of the medical equipment provider’s stock worth $340,000 after acquiring an additional 9 shares during the period. Parkside Financial Bank & Trust increased its holdings in Zimmer Biomet Holdings by 3.9% during the 2nd quarter. Parkside Financial Bank & Trust now owns 872 shares of the medical equipment provider’s stock worth $112,000 after acquiring an additional 33 shares during the period. CWA Asset Management Group LLC increased its holdings in Zimmer Biomet Holdings by 1.8% during the 2nd quarter. CWA Asset Management Group LLC now owns 1,952 shares of the medical equipment provider’s stock worth $251,000 after acquiring an additional 34 shares during the period. Advisory Services Network LLC grew its stake in Zimmer Biomet Holdings by 1.0% in the 2nd quarter. Advisory Services Network LLC now owns 3,690 shares of the medical equipment provider’s stock worth $474,000 after buying an additional 37 shares in the last quarter. Finally, Palladium Partners LLC grew its stake in Zimmer Biomet Holdings by 1.7% in the 2nd quarter. Palladium Partners LLC now owns 2,501 shares of the medical equipment provider’s stock worth $321,000 after buying an additional 41 shares in the last quarter. 85.44% of the stock is currently owned by institutional investors and hedge funds.

A number of research firms have commented on ZBH. Deutsche Bank AG raised shares of Zimmer Biomet Holdings from a “hold” rating to a “buy” rating and set a $128.00 price target for the company in a research note on Tuesday. Oppenheimer Holdings, Inc. set a $137.00 price target on shares of Zimmer Biomet Holdings and gave the stock a “buy” rating in a research note on Friday, July 28th. Piper Jaffray Companies reissued a “buy” rating and issued a $135.00 price target on shares of Zimmer Biomet Holdings in a research note on Friday, July 28th. Zacks Investment Research cut shares of Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a research note on Tuesday, August 1st. Finally, BidaskClub cut shares of Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a research note on Tuesday, August 1st. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $133.71.

TRADEMARK VIOLATION WARNING: This story was published by Watch List News and is owned by of Watch List News. If you are reading this story on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The correct version of this story can be accessed at https://www.watchlistnews.com/prudential-financial-inc-has-33-04-million-position-in-zimmer-biomet-holdings-inc-zbh/1702401.html.

Zimmer Biomet Holdings, Inc. (NYSE ZBH) opened at $111.06 on Tuesday. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.47 and a quick ratio of 0.78. Zimmer Biomet Holdings, Inc. has a 1-year low of $95.63 and a 1-year high of $133.49. The company has a market cap of $22,423.90, a price-to-earnings ratio of 13.72, a price-to-earnings-growth ratio of 1.72 and a beta of 1.17.

Zimmer Biomet Holdings (NYSE:ZBH) last issued its quarterly earnings data on Wednesday, November 1st. The medical equipment provider reported $1.72 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.74 by ($0.02). Zimmer Biomet Holdings had a return on equity of 16.29% and a net margin of 8.36%. The company had revenue of $1.82 billion during the quarter, compared to the consensus estimate of $1.83 billion. During the same quarter last year, the company posted $1.79 earnings per share. The firm’s revenue for the quarter was down .8% compared to the same quarter last year. sell-side analysts predict that Zimmer Biomet Holdings, Inc. will post 8.03 earnings per share for the current fiscal year.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.